Extensive News Coverage For Latest Breakthrough in Chemotherapy-Induced Alopecia Prevention
On 10th July, it was announced that Dr. Nikolaos Georgopoulos and his team at Sheffield Hallam University, supported by Paxman, had published a new research paper in the peer-reviewed journal Frontiers in Pharmacology. A major milestone in scalp cooling innovation, the paper highlights a powerful new way to revolutionise and standardise efficacy, potentially transforming it into a more consistent and universally reliable method of preventing chemotherapy-induced hair loss.
Since then, coverage of this exciting news has been picked up by a wide of range of national media outlets, where local television, radio, and national press have featured Dr. Georgopoulos.
Coverage Highlights
As of 18th July 2025, there have been 28 pieces of coverage across the UK, both online and offline.
Television
Dr. Nik Georgopoulos spoke live on-air during BBC’s regional evening news programme, Look North on 14th July at 6:30pm alongside Fiona, a patient advocate.
Online News
The research by Sheffield Hallam University, in partnership with Paxman, was also featured in many online media outlets, including several mainstream platforms such as the BBC, which described it as a ‘“double weapon” found in chemo hair loss research’.
Sky News and The Independent focused their headlines on the milestone achieved for patients wanting to preserve their hair during chemotherapy.
The Times provided a more descriptive headline towards the news with ‘How a helmet and lotion can spare cancer patients from losing hair’.
There were also several publications aimed at healthcare professionals, including the Clinical Services Journal, Health Tech World, and Healthcare Management.
As of July 18th 2025, the 28 pieces of coverage, is predicted to have reached 1.3 million lifetime views, based on audience reach and engagement rates on social media. Together, the news outlets have a combined audience size of 187 million- the estimated total number of people that visit the websites featuring this coverage.
Full Coverage
See here for a full, up-to-date overview of all the incredible press coverage for this story.
Paxman are constantly looking to advance our scientific understanding of how cooling works and this new research is an exciting development in the possibilities of future approaches to improve efficacy for even more people. We are hopeful that the topical treatment can help protect the follicles further when cooling isn’t enough, but it’s still a little way off, as work begins on formula optimisation, regulatory approvals and formulation scale up processes.
